Department of Chemistry, Indian Institute of Technology Roorkee, Roorkee, 247 667, India.
Dalton Trans. 2010 Feb 7;39(5):1345-60. doi: 10.1039/b915752b. Epub 2009 Dec 1.
Binucleating hydrazones CH(2)(H(2)sal-bhz)(2) (I) and CH(2)(H(2)sal-fah)(2) (II), derived from 5,5'-methylbis(salicylaldehyde) and benzoylhydrazide or 2-furoylhydrazide, react with [V(IV)O(acac)(2)] to give dinuclear V(IV)O-complexes [CH(2){V(IV)O(sal-bhz)(H(2)O)}(2)] 1 and [CH(2){V(IV)O(sal-fah)(H(2)O)}(2)] 4, respectively. In the presence of KOH or CsOH.H(2)O, oxidation of 1 and 2 results in the formation of dioxidovanadium(v) complexes, K(2)[CH(2){V(V)O(2)(sal-bhz)}(2)].2H(2)O 2, K(2)[CH(2){V(V)O(2)(sal-fah)}(2)].2H(2)O 5, Cs(2)[CH(2){V(V)O(2)(sal-bhz)}(2)].2H(2)O 3 and Cs(2)[CH(2){V(V)O(2)(sal-fah)}(2)].2H(2)O 6. These complexes have also been prepared by aerial oxidation of in situ prepared oxidovanadium(iv) complexes 1 and 4. The compounds were characterized by IR, electronic, EPR, (1)H, (13)C and (51)V NMR spectroscopy, elemental analyses and thermogravimetric patterns. Single crystal X-ray analysis of 3 confirms the coordination of the ligand in the dianionic (ONO(2-)) enolate tautomeric form. The V(V)O(2)-complexes were used to catalyze the oxidative bromination of salicylaldehyde, therefore acting as functional models of vanadium dependent haloperoxidases, in aqueous H(2)O(2)/KBr in the presence of HClO(4) at room temperature. It is shown that the V(IV)O-complexes [CH(2){V(IV)O(sal-bhz)(H(2)O)}(2)] 1 and [CH(2){V(IV)O(sal-fah)(H(2)O)}(2)] 4 are catalyst precursors for the catalytic oxidation of organic sulfides using aqueous H(2)O(2). Plausible intermediates involved in these catalytic processes are established by UV-Vis, EPR and (51)V NMR studies. The vanadium complexes along with ligands I and II are also screened against HM1:1MSS strains of Entamoeba histolytica, the results showing that the IC(50) values of compounds 3 and 6 are lower than that of metronidazole. The toxicity studies against human cervical (HeLa) cancer cell line also showed that although compounds 3 and 6 are more toxic than metronidazole towards this cell line, the corresponding IC(50) values are relatively high, the cell viability therefore not being much affected.
双核腙 CH(2)(H(2)sal-bhz)(2) (I) 和 CH(2)(H(2)sal-fah)(2) (II) 是由 5,5'-亚甲基双(水杨醛)和苯甲酰肼或 2-呋喃甲酰肼衍生而来,与 [V(IV)O(acac)(2)] 反应生成双核 V(IV)O 配合物 [CH(2){V(IV)O(sal-bhz)(H(2)O)}(2)] 1 和 [CH(2){V(IV)O(sal-fah)(H(2)O)}(2)] 4。在 KOH 或 CsOH.H(2)O 的存在下,1 和 2 的氧化导致二氧代钒(v)配合物的形成,K(2)[CH(2){V(V)O(2)(sal-bhz)}(2)].2H(2)O 2、K(2)[CH(2){V(V)O(2)(sal-fah)}(2)].2H(2)O 5、Cs(2)[CH(2){V(V)O(2)(sal-bhz)}(2)].2H(2)O 3 和 Cs(2)[CH(2){V(V)O(2)(sal-fah)}(2)].2H(2)O 6。这些配合物也可以通过原位制备的氧化钒(iv)配合物 1 和 4 的空气氧化来制备。这些化合物通过红外、电子、EPR、(1)H、(13)C 和 (51)V NMR 光谱、元素分析和热重模式进行了表征。3 的单晶 X 射线分析证实了配体在阴离子 (ONO(2-))烯醇互变异构形式中的配位。V(V)O(2)-配合物用于在室温下在 HClO(4)存在下,在 H(2)O(2)/KBr 的水溶液中催化水杨醛的氧化溴化,因此作为依赖钒的卤过氧化物酶的功能模型。结果表明,V(IV)O 配合物 [CH(2){V(IV)O(sal-bhz)(H(2)O)}(2)] 1 和 [CH(2){V(IV)O(sal-fah)(H(2)O)}(2)] 4 是催化氧化有机硫化物使用水溶液 H(2)O(2)的催化剂前体。通过 UV-Vis、EPR 和 (51)V NMR 研究确定了这些催化过程中涉及的可能中间体。与配体 I 和 II 一起,这些钒配合物也针对 Entamoeba histolytica 的 HM1:1MSS 菌株进行了筛选,结果表明化合物 3 和 6 的 IC(50)值低于甲硝唑。对人宫颈 (HeLa)癌细胞系的毒性研究也表明,尽管化合物 3 和 6 对该细胞系的毒性比甲硝唑高,但相应的 IC(50)值相对较高,因此细胞活力没有受到太大影响。